Literature DB >> 8754803

The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K.

M L Schmitz1, A Indorf, F P Limbourg, H Städtler, E B Traenckner, P A Baeuerle.   

Abstract

The genomes of human adenoviruses encode several regulatory proteins, including the two differentially spliced gene products E1A and E1B. Here, we show that the 13S but not the 12S splice variant of E1A of adenovirus type 5 can activate the human transcription factor NF-kappaB in a bimodal fashion. One mode is the activation of NF-kappaB containing the p65 subunit from the cytoplasmic NF-kappaB-IkappaB complex. This activation required reactive oxygen intermediates and the phosphorylation of IkappaBalpha at serines 32 and 36, followed by IkappaBalpha degradation and the nuclear uptake of NF-kappaB. In addition, 13S E1A stimulated the transcriptional activity of the C-terminal 80 amino acids of p65 at a core promoter with either a TATA box or an initiator (INR) element. The C-terminal 80 amino acids of p65 were found to associate with E1A in vitro. The activation of NF-kappaB-dependent reporter gene transcription by E1A was potently suppressed upon coexpression of the E1B 19-kDa protein (19K). E1B 19K prevented both the activation of NF-kappaB and the E1A-mediated transcriptional enhancement of p65. These inhibitory effects were not found for the 55-kDa splice variant of the E1B protein. We suggest that the inductive effect of E1A 13S on the host factor NF-kappaB, whose activation is important for the transcription of various adenovirus genes, must be counteracted by the suppressive effect of E1B 19K so that the adenovirus-infected cell can escape the immune-stimulatory and apoptotic effects of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8754803      PMCID: PMC231401          DOI: 10.1128/MCB.16.8.4052

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  102 in total

1.  Reduced binding activity of transcription factor NF-kappa B accounts for MHC class I repression in adenovirus type 12 E 1-transformed cells.

Authors:  I Meijer; A J Boot; G Mahabir; A Zantema; A J van der Eb
Journal:  Cell Immunol       Date:  1992-11       Impact factor: 4.868

2.  The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

Authors:  L Rao; M Debbas; P Sabbatini; D Hockenbery; S Korsmeyer; E White
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 3.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

Authors:  M Grilli; J J Chiu; M J Lenardo
Journal:  Int Rev Cytol       Date:  1993

4.  Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

Authors:  M Debbas; E White
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

5.  Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene.

Authors:  B Levine; Q Huang; J T Isaacs; J C Reed; D E Griffin; J M Hardwick
Journal:  Nature       Date:  1993-02-25       Impact factor: 49.962

6.  Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein.

Authors:  R Schreck; R Grassmann; B Fleckenstein; P A Baeuerle
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

7.  Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines.

Authors:  N Israël; M A Gougerot-Pocidalo; F Aillet; J L Virelizier
Journal:  J Immunol       Date:  1992-11-15       Impact factor: 5.422

8.  Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements.

Authors:  W Du; D Thanos; T Maniatis
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

9.  The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha.

Authors:  E White; P Sabbatini; M Debbas; W S Wold; D I Kusher; L R Gooding
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

10.  Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF.

Authors:  K Schulze-Osthoff; R Beyaert; V Vandevoorde; G Haegeman; W Fiers
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  14 in total

1.  Adenovirus type 5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress and production of reactive oxygen species.

Authors:  Kathleen A McGuire; Arlene U Barlan; Tina M Griffin; Christopher M Wiethoff
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.

Authors:  Kyle D Weaver; Susan Yeyeodu; James C Cusack; Albert S Baldwin; Matthew G Ewend
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

3.  Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins.

Authors:  G M Kasof; L Goyal; E White
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

4.  Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation.

Authors:  Jason B Weinberg; Daniel R Jensen; Lisa E Gralinski; Amy R Lake; Gregory S Stempfle; Katherine R Spindler
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

5.  Identification of a novel antiapoptotic protein, GAM-1, encoded by the CELO adenovirus.

Authors:  S Chiocca; A Baker; M Cotten
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Basal transcription factors TBP and TFIIB and the viral coactivator E1A 13S bind with distinct affinities and kinetics to the transactivation domain of NF-kappaB p65.

Authors:  K Paal; P A Baeuerle; M L Schmitz
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

7.  Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway.

Authors:  M H Heim; D Moradpour; H E Blum
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation.

Authors:  K De Bosscher; M L Schmitz; W Vanden Berghe; S Plaisance; W Fiers; G Haegeman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

9.  Multiple domains in the 50 kDa form of E4F1 regulate promoter-specific repression and E1A trans-activation.

Authors:  Robert J Rooney
Journal:  Gene       Date:  2020-06-11       Impact factor: 3.688

10.  Promyelocytic leukemia protein isoform II inhibits infection by human adenovirus type 5 through effects on HSP70 and the interferon response.

Authors:  Zeenah Atwan; Jordan Wright; Andrew Woodman; Keith N Leppard
Journal:  J Gen Virol       Date:  2016-05-23       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.